Grayslake, IL, United States of America

Jennifer C Freeman


 

Average Co-Inventor Count = 14.8

ph-index = 3

Forward Citations = 273(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Inventor Jennifer C. Freeman

Introduction: Jennifer C. Freeman, an accomplished inventor based in Grayslake, IL, has made significant contributions to the field of pharmaceutical sciences. With a portfolio of 4 patents, her work primarily focuses on developing innovative compounds that address various health concerns, particularly related to metabolism and inflammation.

Latest Patents: Among her latest patents, Freeman has developed antagonists of the melanin concentrating hormone receptor, specifically targeting MCH-R1. This invention presents compounds that hold promise in treating associated disorders, notably obesity. The compounds are characterized by specific structural formulas, where variations in elements can lead to beneficial therapeutic applications. Additionally, she has introduced novel cinnamide compounds that effectively inhibit cell adhesion, aiming to provide solutions for inflammatory and immune diseases. These compounds are integral to formulating pharmaceutical compositions aimed at managing inflammation and immune responses in mammals.

Career Highlights: Jennifer C. Freeman is a key innovator at Abbott Laboratories Corporation, where her research and development efforts focus on breakthrough compounds that enhance patient care and therapeutic outcomes. Over her career, she has demonstrated a commitment to advancing medical science through her inventions, significantly impacting the pharmaceutical landscape.

Collaborations: Throughout her career, Freeman has collaborated with esteemed colleagues in her field, including Steven Armen Boyd and Indrani W. Gunawardana. These partnerships have fostered an environment of innovation and knowledge exchange, aiding in the advancement of their collective research objectives.

Conclusion: Jennifer C. Freeman exemplifies the spirit of innovation in the pharmaceutical industry. Her groundbreaking patents reflect her dedication to improving health outcomes through scientific discovery. As her career progresses, Freeman continues to contribute to the development of new treatments that can positively impact the lives of many.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…